ArticleClinical optometry2024
A Comparative Analysis of Interpupillary Distance Measurement Techniques Evaluation in Modern Times: From Rulers to Apps.
Article in Clinical optometry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Interpupillary Distance and Binocular Vision: Assessing the Association Between Anatomy and Sensory-Motor Functions.Brain sciences · 2026Article
- Review
- Improving interpupillary distance accuracy in the plusoptix A12R: A distance-dependent correction.Journal of optometryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The use of mobile phone applications (apps) in the health sector, including in eye care, is increasing. This study aimed to compare interpupillary distance (IPD) measurements using common clinical techniques (pupillometer, PD ruler, and autorefractor), which are contact procedures, with measurements from a non-contact mobile phone application. Methods: Forty participants were recruited (mean age 25.65±3.72 years, 21 male and 19 female). Binocular distance and near IPD measurements from four instruments were compared: pupillometer (TOPCON PD-5, Japan), PD ruler, auto-refractor (KR-8100P, TOPCON, Japan), and Mobile Application (Eye Measure, 1.22). Two consecutive measurements were performed. The pupillometer measurement was used as the gold standard measurement for the Bland-Altman analysis, and two analyses were conducted: repeated measures ANOVA and Bland- Altman plots to analyze mean differences (MD) and 95% confidence intervals (CI) calculated as MD±1.96* standard deviation (SD). Results: The measurement method affected IPD distance (F(3, 117)=15.74, p<0.01). The mobile apps resulted in significantly smaller distance IPD measurements than other methods. The PD ruler method yielded significantly larger distance IPD measurements than the pupillometer. For binocular near IPD, there was a significant difference among the methods (F(2, 78)=15.06, p<0.01). Pairwise comparison revealed that IPD ruler measurement was greater than with the other two methods (pupillometer and mobile application), while no difference was found between the pupillometer and mobile application. For consistency of measurement, correlation of two consecutive measurements was carried out, and it was found to be strongly correlated for all methods (r=0.9; p.<01). Conclusion: Measurement by different tools showed difference of IPD measurement although induced prism due to discrepancy were within the allowed tolerance of less than 0.33 prism diopter (ISO 16034:2002) for all methods. Therefore, mobile App can be efficiently used for screening purposes for many people where limited services are available. However, caution should be exercised when mobile apps are used, such as in complex and for eyes which are misaligned.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.